Fig. 3.
Fig. 3. CD19+ lymphocyte counts over the course of rituximab treatment and during follow-up. / Each data point represents the mean (± SD) CD19+ cell count at a particular time.

CD19+ lymphocyte counts over the course of rituximab treatment and during follow-up.

Each data point represents the mean (± SD) CD19+ cell count at a particular time.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal